Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
| Metric | AME | EMR |
|---|---|---|
| Price | $250.14 | $158.56 |
| Change today | ▲ 0.97% | ▲ 2.23% |
| Market cap | $57.35B | $88.44B |
| Return, 3 months | – | +14.0% |
| Return, year to date | – | +20.8% |
| Return, 1 year | – | +22.8% |
| P/E (TTM) | 36.6 | 34.7 |
| P/B | 5.1 | 4.3 |
| P/E percentile vs own 5y | 95th | 78th |
| Dividend yield | 0.52% | 1.38% |
| Revenue growth (YoY, latest qtr) | +15.0% | +7.0% |
| Net profit growth (YoY) | +13.5% | +22.5% |
| Gross margin | 36.4% | 53.2% |
| Operating margin | 25.9% | 20.7% |
| Net margin | 20.0% | 13.8% |
| Return on equity | 14.6% | 12.8% |
| Analyst target vs. price | +12.4% | +8.2% |
| Analyst buy share | 71% | 67% |
| RSI (14) | – | 57 |
| 30-day volatility | – | 23.9% |
| Max drawdown, 1 year | – | -23.4% |
| Trend read | – | Strong uptrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
